Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension

Clinica Chimica Acta

Volumn 411, Issue 11-12, 2010, Pages 874-877

  Palei, Ana C T ^a   Sandrim, Valeria C ^b   Duarte, Geraldo ^c   Cavalli, Ricardo C ^c   Gerlach, Raquel F ^c   Tanus Santos, Jose E ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Santa Casa of Belo Horizonte   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Genotype; Gestational hypertension; Haplotype; Matrix metalloproteinases; MMP 9; Preeclampsia

Indexed keywords

ADENINE; CYTOSINE; GELATINASE B; GENOMIC DNA; THYMINE;

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA EXTRACTION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MMP 9 GENE; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; COMPARATIVE STUDY; ENZYMOLOGY; GENETIC MARKER; GENETICS;

ADULT; FEMALE; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATRIX METALLOPROTEINASE 9; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 77954620643     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2010.03.002     Document Type: Article

References (35)

1. Maynard S., Epstein F.H., Karumanchi S.A. Preeclampsia and angiogenic imbalance. Annu Rev Med 2008, 59:61-78.
2. Carty D.M., Delles C., Dominiczak A.F. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 2008, 18:186-194.
3. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994, 101:669-674.
4. Myers J., Mires G., Macleod M., Baker P. In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension 2005, 45:258-263.
5. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839.
6. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
7. Goncalves F.M., Jacob-Ferreira A.L., Gomes V.A., et al. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clin Chim Acta 2009, 403:173-177.
8. Montagnana M., Lippi G., Albiero A., et al. Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. J Clin Lab Anal 2009, 23:88-92.
9. Narumiya H., Zhang Y., Fernandez-Patron C., Guilbert L.J., Davidge S.T. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001, 20:185-194.
10. Tayebjee M.H., Karalis I., Nadar S.K., Beevers D.G., MacFadyen R.J., Lip G.Y. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Am J Hypertens 2005, 18:325-329.
11. Palei A.C., Sandrim V.C., Cavalli R.C., Tanus-Santos J.E. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clin Biochem 2008, 41:875-880.
12. Shimonovitz S., Hurwitz A., Dushnik M., Anteby E., Geva-Eldar T., Yagel S. Developmental regulation of the expression of 72 and 92kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol 1994, 171:832-838.
13. Isaka K., Usuda S., Ito H., et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta 2003, 24:53-64.
14. Sankaralingam S., Arenas I.A., Lalu M.M., Davidge S.T. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006, 8:1-20.
15. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999, 99:1788-1794.
16. Shimajiri S., Arima N., Tanimoto A., et al. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett 1999, 455:70-74.
17. Fernandes K.S., Brum D.G., Sandrim V.C., Guerreiro C.T., Barreira A.A., Tanus-Santos J.E. Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease. J Neuroimmunol 2009, 214:128-131.
18. Coolman M., de Maat M., Van Heerde W.L., et al. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia. Placenta 2007, 28:709-713.
19. Fraser R., Walker J.J., Ekbote U.V., Martin K.L., McShane P., Orsi N.M. Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia. Bjog 2008, 115:1052-1056.
20. Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
21. Demacq C., de Souza A.P., Machado A.A., Gerlach R.F., Tanus-Santos J.E. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. Clin Chim Acta 2006, 365:183-187.
22. Demacq C., Vasconcellos V.B., Marcaccini A.M., Gerlach R.F., Machado A.A., Tanus-Santos J.E. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. Pharmacogenomics J 2009, 9:265-273.
23. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
24. Stephens M., Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 2005, 76:449-462.
25. Demacq C., Vasconcellos V.B., Marcaccini A.M., Gerlach R.F., Silva W.A., Tanus-Santos J.E. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clin Chem Lab Med 2008, 46:57-63.
26. Kuklina E.V., Ayala C., Callaghan W.M. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009, 113:1299-1306.
27. Valdes G., Quezada F., Marchant E., et al. Association of remote hypertension in pregnancy with coronary artery disease: a case-control study. Hypertension 2009, 53:733-738.
28. Wilson B.J., Watson M.S., Prescott G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003, 326:845.
29. Kajantie E., Eriksson J.G., Osmond C., Thornburg K., Barker D.J. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009, 40:1176-1180.
30. Tenhola S., Rahiala E., Martikainen A., Halonen P., Voutilainen R. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J Clin Endocrinol Metab 2003, 88:1217-1222.
31. Sandrim V.C., Palei A.C., Cavalli R.C., et al. Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Repr 2009, 15:115-120.
32. de Vasconcelos D., Izidoro-Toledo T.C., Sandrim V.C., Tanus-Santos J.E., Palei A.C., Cavalli R.C. Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia. Clin Chim Acta 2009, 400:139-141.
33. Sandrim V.C., Palei A.C., Cavalli R.C., et al. eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 2008, 9:1467-1473.
34. Gremlich S., Nguyen D., Reymondin D., et al. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. J Reprod Immunol 2007, 74:143-151.
35. Clark A.G. The role of haplotypes in candidate gene studies. Genet Epidemiol 2004, 27:321-333.